UK to Offer Meningitis B Vaccine to Million Young People Following Outbreak
The UK government has announced a one-off programme offering two doses of the Bexsero meningitis B vaccine to approximately one million school leavers and first-year university students, beginning in late July 2026. The initiative follows the UK's largest-ever MenB outbreak in Kent earlier this year, which resulted in two deaths, alongside further clusters in Dorset and Berkshire. Health officials say the programme targets those at highest immediate risk ahead of the autumn peak in meningococcal disease, while a broader review of routine vaccination is ongoing.
The UK government has announced a one-off MenB vaccination programme covering roughly one million young people — specifically all Year 13 pupils born between 1 September 2007 and 31 August 2008, and those aged under 25 starting university or residential further education for the first time in autumn 2026. The programme uses the Bexsero vaccine, manufactured by GSK, which requires two doses at least 28 days apart and is estimated to provide at least six years of protection; evidence from the existing infant vaccination programme shows it has reduced MenB disease by around 75% in eligible groups. The decision was triggered by an unprecedented outbreak of 21 confirmed MenB cases in Kent in March 2026, causing two deaths, as well as clusters in Weymouth and Reading where a further person died. UKHSA data shows 313 confirmed MenB cases in England in 2024/25, accounting for approximately 83% of all invasive meningococcal disease. Experts note that while overall case numbers are not unusually high, the clustering pattern among young adults is atypical and may signal a shift toward a more active period of the disease's natural cycle, following roughly 25 years of low activity. Eligible individuals in England will be contacted via the NHS app, text, or letter, with appointments available at community pharmacies from late July; Wales and Scotland will run parallel programmes. The Joint Committee on Vaccination and Immunisation (JCVI) is separately assessing whether to recommend a permanent expansion of the routine MenB programme beyond infants.
What's missing
The programme explicitly excludes students already at university (second year and beyond) and younger teenagers outside the Year 13 cohort, groups that charities have flagged as also being at risk; no data on expected vaccine uptake targets or contingency plans if pharmacy capacity proves insufficient have been publicly disclosed.
How coverage differed
The Guardian framed the announcement with greater emphasis on campaigners' calls for a permanent programme and the cost barrier of private vaccination, while the BBC and government sources focused more neutrally on the operational details and public health rationale.
What different sources said
- Sky NewsCenter
Meningitis B jab to be offered to one million young people
- BBCCenter
Meningitis B vaccine to be offered to thousands of young people in July
- BBC Top StoriesCenter
Meningitis B vaccine to be offered to a million young people
UK school leavers and new students to be offered meningitis B vaccine
- The Straits TimesCenter
Britain offers meningitis shot to 1 million students after outbreak
- CBCLeft
Trio of cases in central Newfoundland prompts advisory on meningococcal disease
- MadeForMumsCenter
Million young people to be offered meningitis B vaccine ahead of university
- GOV.UKCenter
Thousands of young people to be offered two-dose MenB vaccine
NHS England commissions community pharmacies to deliver MenB vaccines to young people
- Times of IndiaCenter
Meningitis B vaccine rollout: Who is eligible and what symptoms to watch for
- Wired-GovCenter
Thousands of young people to be offered two-dose MenB vaccine
- Yahoo FinanceCenter
Young people urged to get meningitis B vaccine
Related
Chicago Woman's Five-Year Symptom Journey Leads to Rare Brain Tumor Diagnosis
Melony Aponte, 26, was diagnosed with a 4.5-centimeter acoustic neuroma after five years of symptoms she attributed to stress, COVID-19, and aging. The rare, noncancerous tumor—affecting roughly one in 100,000 people—had grown large enough to compress her hearing and balance nerve before it was identified via MRI in March 2025. Her case highlights how acoustic neuroma symptoms can mimic common conditions, potentially delaying diagnosis for years.
Study Finds Aging Shifts Walking Strategy Toward Stability at the Cost of Efficiency
A new study from Flinders University and the University of Canberra found that as people age, their bodies adopt a 'safety-first' walking pattern that prioritizes balance over efficient movement. Researchers analyzed gait data from 107 healthy adults aged 26 to 86, identifying increased ankle muscle co-contraction and reduced push-off power as key age-related changes. The findings suggest that fall prevention programs should target balance and coordination, not just muscle strength.
Tick Populations Surge in Urban Areas Across Northeast
Experts across the northeastern United States and Canada are warning of an unusually early and widespread tick season, with disease-carrying ticks increasingly found in urban parks and green spaces. Lyme disease cases in Canada reached a record 7,105 in 2025, up from 5,809 the previous year, while U.S. cities including Philadelphia, Pittsburgh, Washington D.C., and New York are reporting rising tick activity. The expansion poses a public health challenge because urban residents are less likely to take tick-bite precautions than those in rural areas.